CAP-53194
Code | Size | Price |
---|
TAR-T23849-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T23849-50mg | 50mg | £1,661.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T23849-100mg | 100mg | £2,079.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
CAP-53194 is a selective Plk1 inhibitor.
CAS:
660817-08-3
Formula:
C21H14N6O5
Molecular Weight:
430.38
Purity:
0.98
SMILES:
[O-][N+](=O)c1ccc(NC(=O)c2nnn(c2-c2ccccc2)-c2ccc(cc2)[N+]([O-])=O)cc1
References
1. Shino N, Uchida T, Yoshida M, Nomura Y. Development and Assessment of a Nomogram to Propose the Initial Dosage Regimen of a Meropenem Infusion Based on Serum Creatinine and Age Using a Monte Carlo Simulation. Chem Pharm Bull (Tokyo). 2015;63(12):986-91. doi: 10.1248/cpb.c15-00494. PubMed PMID: 26633021.
2. Wang L, Kim M, Fang Q, Min J, Jeon WI, Lee SY, Son SJ, Joo SW, Lee SB. Hydrophobic end-gated silica nanotubes for intracellular glutathione-stimulated drug delivery in drug-resistant cancer cells. Chem Commun (Camb). 2013 Apr 21;49(31):3194-6. doi: 10.1039/c3cc38761e. Epub 2013 Feb 15. PubMed PMID: 23417143.